CC Shareholder Alert: December 7, 2026 Lead Plaintiff Deadline in The Chemours Company Securities Class Action - Contact Levi & Korsinsky
Wall Street Reassessment: Analyst Opinion Evolution on CC. UBS, Morgan Stanley, and J.P. Morgan cut Chemours price targets by as much as 37.9% after a 2026 guidance cut that the lawsuit alleges followed months of overstated Opteon aftermarket demand. NEW YORK, Oct. 14, 2026 /PRNewswire/...
Covered in this story
Analyst targets on Chemours
- RBC Capital Markets: $13.4 → $14 by Oct 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Chemours →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.